Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 956355 10.3389/fphar.2022.956355 Pharmacology Review Targeting Oxidative Stress and Inflammation in Intervertebral Disc Degeneration: Therapeutic Perspectives of Phytochemicals Kang et al. Potential of Phytochemicals Against IDD Kang Liang † Zhang Huaqing † Jia Chongyu † Zhang Renjie * Shen Cailiang * Department of Orthopedics and Spine Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China

Edited by: Cheng Chen, Hefei Institutes of Physical Science (CAS), China

Reviewed by: Jun Zou, Soochow University, China

Weishi Li, Peking University Third Hospital, China

 *Correspondence: Renjie Zhang, zhangrenjie1089@126.com; Cailiang Shen, shencailiang@ahmu.edu.cn

These authors have contributed equally to this work and share first authorship

This article was submitted to Inflammation Pharmacology, a section of the journal Frontiers in Pharmacology

 12 07 2022 2022 13 956355 30 05 2022 20 06 2022 Copyright © 2022 Kang, Zhang, Jia, Zhang and Shen. 2022 Kang, Zhang, Jia, Zhang and Shen

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Low back pain is a major cause of disability worldwide that declines the quality of life; it poses a substantial economic burden for the patient and society. Intervertebral disc (IVD) degeneration (IDD) is the main cause of low back pain, and it is also the pathological basis of several spinal degenerative diseases, such as intervertebral disc herniation and spinal stenosis. The current clinical drug treatment of IDD focuses on the symptoms and not their pathogenesis, which results in frequent recurrence and gradual aggravation. Moreover, the side effects associated with the long-term use of these drugs further limit their use. The pathological mechanism of IDD is complex, and oxidative stress and inflammation play an important role in promoting IDD. They induce the destruction of the extracellular matrix in IVD and reduce the number of living cells and functional cells, thereby destroying the function of IVD and promoting the occurrence and development of IDD. Phytochemicals from fruits, vegetables, grains, and other herbs play a protective role in the treatment of IDD as they have anti-inflammatory and antioxidant properties. This article reviews the protective effects of phytochemicals on IDD and their regulatory effects on different molecular pathways related to the pathogenesis of IDD. Moreover, the therapeutic limitations and future prospects of IDD treatment have also been reviewed. Phytochemicals are promising candidates for further development and research on IDD treatment.

 intervertebral disc degeneration oxidative stress inflammation phytochemicals therapeutic implication 81772408 National Natural Science Foundation of China10.13039/501100001809 Introduction

Low back pain (LBP) is one of the most prevalent musculoskeletal disorders in the world, and it is estimated that nearly 80% of the population suffers from LBP during their lifetime. The occurrence of LBP in a patient induces a severe burden on their families and society. Intervertebral disc (IVD) degeneration (IDD) is currently believed to be an essential cause of LBP, and it forms the pathophysiological basis of several spinal degenerative diseases, such as intervertebral disc herniation and spinal stenosis (Wang et al., 2014; Vo et al., 2016; Oichi et al., 2020). The conservative clinical treatment for the early stages of IDD primarily includes nonsteroidal anti-inflammatory drugs, physical therapy, and rest. However, such treatment is limited to reducing or controlling pain and does not reverse the process of IDD. Moreover, the long-term use of nonsteroidal anti-inflammatory drugs has apparent side effects (Conaghan, 2012; Bindu et al., 2020). If IDD develops to an advanced stage, surgical treatment, including discectomy and interbody fusion, is required. Although surgical treatment is recommended to be effective for IDD, it is expensive and is associated with several complications, such as adjacent segment disease (Lau et al., 2021), decreased spinal mobility, and limited function. Hence, it is imperative to explore new methods for the treatment of IDD.

The IVD, which is the largest avascular structure, is an important component of the load-bearing capacity of the spine. It comprises three distinct regions: the centrally located nucleus pulposus (NP), peripheral annulus fibrosus (AF) surrounding NP, and cartilage endplate (CEP) located above and below (Adams and Roughley, 2006). The NP is composed mainly of water and a rich extracellular matrix (ECM), which provides resistance to IVD against axial pressures that are transmitted down the spine. The AF consists of concentrically arranged fibrous layers (15–25 layers) that resist the lateral expansion of the IVD during weight-bearing activities. The CEP not only seals the IVD, but also attaches it to the vertebral body. Most importantly, CEP furnishes a permeable barrier between the IVD and the vertebral body to provide nutrition for the IVD cells, but its ability to provide nutrition is limited. Therefore, it is difficult for IVD to repair itself in case of injury (Freemont, 2009).

The presence of three distinct anatomical regions generates the structural complexity of the disc. Healthy discs transmit and absorb stresses in the spine and maintain the multi-axial flexibility of the spine. In contrast, degenerating discs show structural damage that is characterized by high disc collapse, AF rupture, NP tissue loss, decreased water content, and CEP calcification (Ding et al., 2013). IDD is a multifactorial disease with etiologies including infection, genetic susceptibility, aging, trauma, smoking, and diabetes. Many signaling pathways and effector molecules have been implicated in the IDD process, and elucidation of the pathological mechanisms of IDD will facilitate the improvement of its treatment options. Recently, a growing number of studies have revealed a close relationship between inflammation, oxidative stress, and the incidence of IDD (Dowdell et al., 2017). Therefore, antioxidant and anti-inflammatory treatments have been proposed as promising strategies for the treatment of IDD. The following section details the roles of inflammation and oxidative stress in the pathogenesis of IDD.

 Inflammation in Intervertebral Disc Degeneration

Increasing evidence has shown that inflammation is implicated in the occurrence and development of IDD. Several pro-inflammatory cytokines, such as IL-6, IL-17, IL-1α, TNF-α, IL-1β, and IL-8, significantly contribute to an increase in degenerative IVD. These cytokines are closely associated with several key pathophysiological processes of IDD (Johnson et al., 2015; Wang Y. et al., 2020). IL-1β stimulation has been reported to significantly enhance the expression of IL-6, IL-8, and IL-17 in human IVD cells, resulting in an inflammatory cascade. Simultaneously, a feedback loop is formed between these pro-inflammatory cytokines, which forms a persistent local inflammatory microenvironment (Jimbo et al., 2005; Jia et al., 2020). Furthermore, the balance between catabolism and anabolism of ECM is essential for maintaining the structural and functional integrity of IVD, i.e., if the ECM catabolic activity is higher than anabolic activity, it can result in the occurrence of IDD. The primary enzymes that cleave ECM components include matrix metalloproteinases (MMPs) and a disintegrin and metalloprotease with thrombospondin motifs (ADAMTS) (Le Maitre et al., 2007; Vo et al., 2013). Some ECM-degrading enzymes, such as MMP-1/3/7/9 and ADAMTS-1/4/5/9 are significantly increased in degenerative IVD (Le Maitre et al., 2007). Furthermore, pro-inflammatory cytokines can contribute to ECM degradation and the subsequent destruction of the IVD structure by promoting the expression of ECM-degrading enzymes. Apoptosis refers to the spontaneous and orderly death of cells regulated by genes in order to maintain tissue homeostasis. Under physiological conditions, apoptosis plays an important role in maintaining tissue homeostasis. However, in the pathological state, excessive apoptosis stimulated by risk factors will lead to a significant reduction in the number of IVD cells, resulting in the destruction of the structure and function of IVD. Notably, several studies have shown that pro-inflammatory cytokines can induce apoptosis of IVD cells, and then lead to the occurrence and development of IDD. Cell senescence is an irreversible cell cycle arrest caused by a number of factors, such as oxidative stress, pro-inflammatory cytokines, DNA damage. Senescent cells are active and exhibit pro-inflammatory and catabolic phenotypes. Pro-inflammatory cytokines can also accelerate the senescence of IVD cells. Senescent cells can produce more matrix-degrading enzymes and pro-inflammatory cytokines, resulting in further deterioration of the IVD microenvironment (Zhang et al., 2020). Recently, the relationship between inflammation and oxidative stress has also attracted much attention. Pro-inflammatory cytokines have been proved to promote the excessive production of ROS in IVD cells, and then induce oxidative injury of IVD cells (Wang Y. et al., 2020). Vascular endothelial growth factor (VEGF) is an essential member of the pro-angiogenic factor. The expression of VEGF in degenerative IVD is significantly upregulated. Studies have revealed that pro-inflammatory cytokines can upregulate the expression of VEGF in IVD (Kwon et al., 2017). Most importantly, these pro-inflammatory factors can induce stimulation of sinus vertebral nerve endings (Ohtori et al., 2012a; Ohtori et al., 2012b). These nerve endings grow into the IVD and cause nerve root pain (Freemont et al., 2002; Orita et al., 2010), which is the main cause of chronic LBP (Johnson et al., 2001). These findings highlight that inflammation has a central role in the pathogenesis of IDD (Francisco et al., 2022) and suggest that anti-inflammatory strategies can be promising for the treatment of IDD.

 Oxidative Stress in Intervertebral Disc Degeneration

Reactive oxygen species (ROS) are unstable and highly reactive molecules (Feng et al., 2017). They include superoxide anions (O2 −), hydrogen peroxide (H2O2), hydroxyl radicals (OH−), and hypochlorite ions (OCL−) (Cao et al., 2022). They are the by-products of oxidative metabolism (Reuter et al., 2010; Kim and Yim, 2015). Although the nutrition supply of IVD is low, the NP, AF, and CEP cells are not anaerobic (Bartels et al., 1998; Lee et al., 2007). During IDD, neovascularization increases the blood supply in IVD cells, thereby increasing the nutrient supply, which promotes ROS production from the original nutrient-deficient disc cells and results in oxidative stress (Gille and Nohl, 2001; Turrens, 2003). Oxidative stress is attributed to an imbalance between ROS production and the protective mechanism of antioxidants, resulting in molecular oxidative damage and cell destruction, which has adverse implications on the body. Studies have shown that ROS are widely involved in signal transduction, metabolic regulation, apoptosis, cell senescence, and the phenotypic transformation of cells in IDD (Feng et al., 2017; Cao et al., 2022). Excessive ROS activates the NF-κB and MAPK pathways, resulting in an imbalance between degradation and synthesis of ECM in disc cells and an increase in the secretion of pro-inflammatory factors. These changes eventually lead to the loss of disc cells and the persistence of the inflammatory microenvironment, which further leads to the destruction of IVD and the production of ROS (Zhou et al., 2010; Zhu et al., 2019). Autophagy is a protective process in which cells degrade metabolic waste and further reuse it; however continuous oxidative stress can induce excessive autophagy and lead to cell death (Chen et al., 2015; Filomeni et al., 2015; Cao et al., 2022). In addition, oxidative stress can destroy mitochondria and release pro-apoptotic molecules from the mitochondria into the cytoplasm, causing cascade reactions and cell apoptosis (Chen et al., 2014; Yang et al., 2015). Excessive ROS production can also promote IVD cell senescence, thus promoting the secretion of pro-inflammatory factors, leading to adjacent IVD cell senescence, apoptosis, and ECM degradation (Dimozi et al., 2015). Moreover, the increase of ROS production leads to the triggering of glycosylation reaction which further results in the increase of endogenous active by-products and the generation of advanced glycation end products (AGEs) (Vistoli et al., 2013). AGEs have been proved to be closely related to the pathogenesis of IDD. They can promote the inflammation, apoptosis, and ECM degradation of IVD cells, resulting in the destruction of IVD structure and function (Song et al., 2017; Song et al., 2018). These findings indicate that antioxidation is a new and effective treatment for IDD. Figure 1 provides an overview of the mechanisms by which inflammation and oxidative stress participate in the occurrence and development of IDD.

Inflammation and oxidative stress are involved in multiple pathological processes of IDD.

 Phytochemicals for the Treatment of IDD by Targeting Inflammation and Oxidative Stress

In recent years, several phytochemicals from traditional medicinal plants have been studied owing to their low cost, wide availability, and diverse biological activities. Owing to their anti-inflammatory and antioxidant properties, phytochemicals have been used to treat several diseases, such as myocardial ischemia, traumatic brain injury, osteoarthritis, and cancer (Cai et al., 2021; Deng et al., 2021; Tian et al., 2021; Chen C. et al., 2022). Several in vivo and in vitro experiments (Zhu et al., 2020; Chen et al., 2021) have shown that phytochemicals can play a protective role against IDD by targeting inflammation and oxidative stress. The effects and mechanisms of various phytochemicals against IDD are described in the following sections (Table 1).

Phytochemicals possess multiple pharmacological effects via the anti-inflammatory and antioxidant mechanism in various in vitro and in vivo models of IDD.

Phytochemical Study model Dosage range Signal pathways/Mechanisms References
Curcumin In vitro, TBHP induced human NP cells 5, 10, 15, 20, 25 μM inhibited oxidative stress and mitochondrial dysfunction through AMPK/mTOR/ULK1 pathway-induced autophagy and -enhanced autophagic flux Kang et al. (2019)
In vivo, a needle puncture induced rat IDD model 100 mg/kg via intraperitoneal injection, twice weekly for 1 month
Resveratrol In vitro, SNP induced rat NP cells 10, 50, 100, 200, 400 μM inhibited SNP-induced NP cell apoptosis by reducing ROS production Li et al. (2018)
Ex vivo, SNP induced organ culture of IVD 100 μM
In vitro, IL-1β induced rat NP cells 50 μM reduced the expression levels of inflammatory factors in NP cells Wuertz et al. (2011)
Mangiferin In vitro, TNF-α induced human NP cells 100 μM, 500 μM inhibited NP cell apoptosis and ECM degeneration by inhibiting the production of inflammatory factors and ROS; NF-κB signaling pathway Yu et al. (2021)
In vivo, a needle puncture induced rat IDD model 0.2 μg via intradiscal injection 3 days after puncture
(-)-Epigallocatechin-3-gallate In vitro, H2O2 induced human NP cells 5 μM, 25 μM inhibited the expression level of inflammatory mediators and apoptosis; cGAS/Sting/NLRP3 pathway Tian et al. (2020)
Chlorogenic acid In vitro, IL-1β induced mice CEP cells 6.25, 12.5, 25 μM inhibited the expression of inflammatory mediator and ECM degradation; NF-κB pathway Ge et al. (2021)
Icariin In vitro, IL-1β induced human NP cells 0.1, 1, 10 μM inhibited the level of PGE2, NO, iNOS, COX-2 and ECM degradation; MAPK pathway and NF-κB pathway Hua et al. (2018)
In vitro, H2O2 induced human NP cells 0.1, 1, 10 μM inhibited the production of ROS induced by H2O2; alleviated the human NP cell apoptosis; Nrf2 pathway Hua et al. (2020)
Lycopene In vitro, H2O2 induced human NP cells 2.5 μm, 5 μm Inhibited the apoptosis and ECM degradation; Nrf2 pathway Lu et al. (2020)
Celastrol In vitro, IL-1β induced human NP cells 10, 50, 100, 200 nM Inhibited the apoptosis, ECM degradation, inflammation; NF-κB pathway Chen et al. (2017)
Isofraxidin In vitro, IL-1β induced human NP cells 10, 20, 40 μM inhibited the level of PGE2, NO, iNOS, COX-2, TNF-α, and IL-6; NF-κB pathway Su et al. (2019)
Higenamine In vitro, IL-1β induced human NP cells 10, 20, 40 μM inhibited the level of PGE2, iNOS, COX-2, TNF-α, and IL-6; NF-κB pathway Bai et al. (2019)
Sesamin In vitro, LPS induced rat NP cells 0.1, 0.5, 1 μM suppressed the expression of inflammation factors and the migration of macrophages induced by LPS; MAPK pathway Li et al. (2016)
Ex vivo, LPS induced organ culture of IVD 10 μg/ml
In vivo, a needle puncture induced rat IDD model 0.1 M via intradiscal injection immediately after lesion of the disc Li and Lv, (2020)
Honokiol In vitro, H2O2 induced rat NP cells 2.5μM, 5 μM inhibited the production of oxidative stress marker molecules (ROS, MDA) and the level of inflammatory mediators (IL-6, COX-2 and iNOS) in NP cells; NF-κB pathway, JNK signal, TXNIP/NLRP3/caspase-1/IL-1β signal axis Tang et al. (2018)
In vivo, a needle puncture induced rat IDD model 30 mg/kg via intraperitoneal injection, twice weekly for 2 month
In vitro, TBHP induced rat NP cells 1, 5, 10 μM improved mitochondrial antioxidant capacity, mitochondrial function, and prevented oxidative stress in NP cells; AMPK-PGC-1α signaling pathway Wang et al. (2018b)
In vivo, a needle puncture induced rat IDD model 40 mg/kg via oral administration for 1 week
Salvianolic acid B In vitro, H2O2 induced rat NP cells 0.001, 0.01, 0.1, 1, 10, 100 nM reduced the levels of ROS and MDA and increased the levels of GSH and SOD2 Dai et al. (2021b)
In vivo, a needle puncture induced rat IDD model 20 mg/kg via oral gavage, once per day for six consecutive weeks
Polydatin In vitro, TNF-α induced rat NP cells 200 μM, 400 μM reduced the production of ROS through Nrf2 signaling pathway Wang et al. (2018a)
In vivo, a needle puncture induced rat IDD model 50 mg/kg via intragastric administration, once per day for 4 weeks
In vitro, H2O2 induced human CEP cells 200 μM upregulated Parkin and Nrf2 pathway, protecting CEP cells from H2O2-induced mitochondrial dysfunction, oxidative stress and apoptosis Kang et al. (2020)
Naringin In vitro, TNF-α induced human NP cells 5 μg/ml, 10 μg/ml, 20 μg/ml prevented NP cells from inflammatory response, oxidative stress and impaired cellular homeostasis; AMPK/SIRT1 pathway Chen et al. (2022b)
Baicalein In vitro, IL-1β induced rat NP cells 5, 25, 50 μM inhibited the level of NO, PGE2, TNF-α and IL-6 induced by IL-1β in NP cells; NF-κB and MAPK pathways Jin et al. (2019)
In vivo, a needle puncture induced rat IDD model 20 mg/kg via intraperitoneal injection, once daily
Berberine In vitro, H2O2 induced human NP cells 1, 2, 4, 8 μM inhibited oxidative stress-induced cell damage by regulating ER stress and autophagy; IRE1/JNK pathway Luo et al. (2019)
In vivo, a needle puncture induced rat IDD model 150 mg/kg via intraperitoneal injection, once per day for 8 weeks
In vitro, IL-1β induced human NP cells 25 μM inhibited inflammation-induced cell injury Lu et al. (2019)
Genistein In vitro, TBHP induced rat NP cells 50 μM, 100 μM inhibited TBHP-induced apoptosis and ECM degradation; Nrf2 pathway Wang et al. (2019)
In vivo, a needle puncture induced rat IDD model 100 mg/kg/day via intragastric administration for 1 week before surgery
Acacetin In vitro, TBHP induced rat NP cells 0.3 μM, 1 μM inhibited TBHP-induced ROS production in NP cells; reduced the expression of inflammatory mediators such as COX-2 and iNOS; Nrf2 and MAPK pathway Wang et al. (2020b)
In vivo, a needle puncture induced rat IDD model 25 mg/kg via intraperitoneal injection, once weekly for 4 months
Wogonin In vitro, IL-1β induced rat NP cells 10, 25, 50 μM Inhibited IL-1β-induced inflammatory response and extracellular matrix degradation in NP cells Fang et al. (2018)
Luteoloside In vitro, IL-1β induced rat NP cells 2, 5, 10 μM inhibited IL-1β-induced the level of NO, PGE2, TNF-α, IL-6, COX-2, and iNOS in rat NP cells; Nrf2/NF-κB pathway Lin et al. (2019)
In vivo, a needle puncture induced rat IDD model 10 mg/kg via intraperitoneal injection, once daily
Quercetin In vitro, TBHP induced rat NP cells 5, 15, 30, 60 μM reduced ROS by activating SIRT1-autophagy pathway Wang et al. (2020a)
In vivo, a needle puncture induced rat IDD model 100 mg/kg via intraperitoneal injection, three times weekly for 8 weeks
Curcumin

Curcumin (CUR)—an active polyphenol extracted from the dried rhizomes of Curcuma longa—has been traditionally used for dietary and medical purposes worldwide (Li KX. et al., 2022; Jin et al., 2022; Ojo et al., 2022). CUR shows a wide range of pharmacological activities, including anti-inflammatory and antioxidant activities, in various disease models (Yang et al., 2020; Uddin et al., 2021; Fan and Lei, 2022). Kang et al. confirmed the protective effect of CUR against IDD using in vivo and in vitro experiments (Kang et al., 2019). CUR induces autophagy and enhanced autophagic flux via the AMPK pathway (Kang et al., 2019), thereby inhibiting oxidative stress and mitochondrial dysfunction. Moreover, the apoptosis, ECM degradation, and senescence were reversed by CUR in NP cells that were treated with tert-butyl hydroperoxide (TBHP). This study provides sufficient evidence suggesting that CUR delays IDD development by inhibiting oxidative stress.

 Resveratrol

Resveratrol (RES) is a polyphenolic compound present in many plants, such as berries and peanuts (Li KX. et al., 2021; Izzo et al., 2021). It has strong protective effects against many diseases, such as osteoarthritis and cancer (Mobasheri et al., 2012; Nguyen et al., 2017; Xiao et al., 2018; Deng et al., 2019; Cháirez-Ramírez et al., 2021). Li et al. found that RES protects rat NP cells from apoptosis induced by sodium nitroprusside by scavenging ROS in vitro experiments (Li et al., 2018). Moreover, ex vivo experiments showed that RES could reduce the development of experimental IDD. The secretion of pro-inflammatory cytokines by IVD cells appears to be the key mediator in the development of pain. Wuertz et al. found that RES significantly reduces the expression of IL-6 and IL-8 in NP cells (Wuertz et al., 2011). Therefore, RES may inhibit the progression of IDD through its dual effects of anti-inflammatory and antioxidant activities. Hence, it can be explored as a new method for IDD treatment.

 Mangiferin

Mangiferinis mainly extracted from Mangifera persiciformis, Anemarrhena asphodeloides, and Mangifera indica (Akter et al., 2022; Wang et al., 2022). It plays an important role in the progression of kidney disorders (Lum et al., 2022), diabetes (Aswal et al., 2020), cancer (Morozkina et al., 2021), and osteoarthritis (Qu et al., 2017; Li et al., 2019). It has crucial anti-inflammatory (Wang R. et al., 2021; Li N. et al., 2021) and antioxidant functions (Huang et al., 2020; Samadarsi and Dutta, 2020; Ismail et al., 2021); its application has also been reported in the treatment of IDD. Yu et al. found that mangiferin treatment can inhibit the loss of ECM by inhibiting TNF-α-induced inflammatory cytokines such as iNOS and COX-2 (Yu et al., 2021). In addition, it can alleviate mitochondrial damage and apoptosis indicators, such as cleaved-caspase-3 and Bax, by reducing ROS production. Moreover, in vivo experiments have confirmed the protective effect of mangiferin against IDD (Yu et al., 2021). These results suggest that mangiferin can provide a potential treatment for IDD.

 (-)-Epigallocatechin-3-Gallate

(-)-Epigallocatechin-3-gallate (EGCG) is a polyphenol that is abundantly found in tea (Butt et al., 2015). EGCG shows a variety of functions in many diseases, such as antiarteriosclerosis (Liu S. et al., 2017), antioxidant (Park et al., 2021), antibacterial (Noor Mohammadi et al., 2019), anti-inflammatory (Ma et al., 2021), and anti-tumor activities (Farabegoli and Pinheiro, 2022). The flow cytometry results of the study (Tian et al., 2020) conducted by Tian et al. showed that EGCG could inhibit the apoptosis and cell cycle arrest induced by H2O2. Western blot results showed that EGCG upregulates the anti-apoptotic proteins expression and downregulates the pro-apoptotic protein expression in H2O2-treated cells. Tian et al. analyzed the expression of IL-6,IL-1β, IL-10, and TNF-α in NP cells to explore the effect of EGCG on the NP cell’s inflammatory response. It was found that H2O2 could promote their expression, whereas EGCG could reverse the changes induced by H2O2. These results suggest that EGCG may be an alternative treatment for IDD.

 Chlorogenic Acid

Chlorogenic acid (CGA) is a natural biologically active compound that is abundantly present in coffee, fruits, and vegetables (Nwafor et al., 2022). It is also the main active ingredient in Chinese herbal medicines, such as Honeysuckle and Eucommia. Its biological functions in disease treatment, such as antioxidant, anti-inflammatory, and immune protective functions, have attracted considerable attention (Liang and Kitts, 2015; Bagdas et al., 2020; Kzhyshkowska, 2022). Ge et al. showed that CGA could reverse the downregulation of aggrecan, the main protein involved in the extracellular matrix anabolism of CEP cells induced by IL-1β, and inhibit the upregulation of MMP-13, the main protein involved in extracellular matrix catabolism (Ge et al., 2021). It can also inhibit the expression of inflammatory factors. Exploration of the molecular mechanisms revealed that the NF-κB signaling is the anti-degenerative effector molecule of CGA. Considering the important role of the NF-κB in the pathogenesis of IDD, these results suggest that CGA can reverse IDD development by regulating this pathway.

 Icariin

Icariin (ICA) is a flavonoid compound extracted from the widely known Chinese herbal medicine Epimedium (Wang M. et al., 2020), which is also recognized as “Yin Yang Huo”. ICA has been revealed by many studies to play a crucial role in antioxidation (Liu XJ. et al., 2021; Zheng et al., 2021) and anti-inflammatory (Guangtao et al., 2021; Zhang et al., 2022). Hua et al. found that IL-1β induces significant expression of COX-2 and iNOS and stimulates the production of PGE2 and nitric oxide in human NP cells (Hua et al., 2018). ICA usage can significantly reduce the levels of these inflammatory mediators. In addition, ICA reduces the expression levels of MMP-3/9/13 and ADAMTS-4/5 induced byIL-1β and increases the expression levels of type II collagen and aggrecan (Hua et al., 2018). A molecular mechanism study showed that MAPK and NF-κB are closely related to ICA. The research group also conducted relevant studies on oxidative stress. They found that ROS production increased in H2O2-treated human NP cells; however, this increase was inhibited by ICA in a dose-dependent manner (Hua et al., 2020). ICA can inhibit the mitochondrial cytochrome c translocation to cytoplasm, decrease Bax and caspase-3 levels, and increase Bcl-2 in H2O2-treated NP cells (Hua et al., 2020). The Nrf2 signaling pathway is an important member of the anti-oxidative stress system in cells. It has been shown to be involved in the antioxidant effects of ICA. Therefore, the study of ICA against inflammation and oxidative stress to maintain IVD cell homeostasis could prove the significance of ICA in the treatment of IDD.

 Lycopene

Lycopene is a naturally occurring, effective antioxidant found in reddish pink-colored fruits and vegetables, such as tomatoes (Mozos et al., 2018). The human body cannot synthesize lycopene and must be ingested through the diet. The powerful antioxidant effects of lycopene have attracted considerable attention and have been verified in many disease models (Müller et al., 2016; Chen et al., 2019; Imran et al., 2020). The upregulation of Bax and downregulation of Bcl-2 in H2O2-treated human NP cells were attenuated by lycopene (Lu et al., 2020). Flow cytometry also showed that lycopene inhibits NP cell apoptosis. In addition, lycopene can promote the expression of type II collagen, aggrecan, and Sox9, in NP cells. The molecular mechanism of lycopene involves Nrf2, which is a powerful antioxidant transcription factor closely related to the role of lycopene in H2O2-treated human NP cells. Therefore, lycopene has the potential to mediate antioxidation and treat IDD.

 Celastrol

Celastrolis a natural triterpenoid found in Tripterygium wilfordii that has been used to treat a variety of common diseases because of its strong anti-inflammatory activity (Jing et al., 2021; Zhu et al., 2021; Li M. et al., 2022). Celastrol can inhibit the upregulation of IL-6andTNF-α expression in NP cells induced by IL-1β (Chen et al., 2017). IL-1β can promote the MMP-3/9/13 and ADAMTS-4/5 expression. Celastrol inhibits the upregulation of these ECM-degrading enzymes. Moreover, since NF-κB acts as a crucial factor in promoting the inflammatory responses during IDD, celastrol can inhibit the activation of the NF-κB pathway (Chen et al., 2017). Therefore, celastrol has the potential for the treatment of IDD.

 Isofraxidin

Isofraxidin is a coumarin compound found in traditional Chinese herbs (Majnooni et al., 2020) and has been clearly shown by previous studies to have strong anti-inflammatory activity (Lin et al., 2018; Chen et al., 2020). Su et al. found that isofraxidin alleviated the IL-1β-induced upregulation of inflammatory mediators and cytokines (Su et al., 2019). In NP ECM metabolism, it can inhibit the expression of the ECM-degrading enzymes and promote the expression of type II collagen and aggrecan. In terms of the molecular mechanism, isofraxidin can inhibit the nuclear translocation and phosphorylation of p65, indicating that the NF-κB pathway is involved in the anti-inflammatory effect of isofraxidin. These studies show that isofraxidin can be used for treating IDD.

 Higenamine

Higenamine was extracted initially from the traditional Chinese herb aconite root in 1976 and later was identified as the main active component of many Chinese herbs (Ha et al., 2012). Higenamine has been found to have many biological activities (Bai et al., 2019; Zhang et al., 2019; Romeo et al., 2020; Yang et al., 2021), such as anti-inflammatory and antioxidant. Bai et al. found that the IL-1β-induced iNOS, PGE2, COX-2, TNF-α, and IL-6 levels, were attenuated by higenamine in NP cells (Bai et al., 2019). Moreover, Bai et al. have also found that higenamine suppressed the IL-1β-induced activation of the NF-κB signaling pathway.

 Sesamin

Sesamum indicum (sesame) is often used as a source of spices and edible oil. Sesamin is a type of sesame lignans that can be extracted from sesame oil (Dalibalta et al., 2020). Many studies have shown that sesamin has potential anti-inflammatory, antioxidant, and anti-tumor effects in different tissues (Majdalawieh et al., 2017; Dalibalta et al., 2020). The role of sesamin in IDD development has also been confirmed. The anti-inflammatory effects of sesamin on rat IVD have been examined by Li et al. The expression of inflammation factors and the migration of macrophages can be suppressed by sesamin treatment (Li et al., 2016). Subsequently, the inhibition of MAPK pathway activation was involved in its anti-inflammatory effect. In addition, Li et al. proved the inhibitory effects of sesamin on the occurrence and development of IDD through in vivo experiments (Li and Lv, 2020). These results suggest that sesamin can reverse the process of IDD by inhibiting inflammation.

 Honokiol

Honokiol (HKL) is a natural compound extracted from the roots and bark of Magnolia trees (Prasad and Katiyar, 2016). Previous studies have shown that it has apparent antagonistic effects on oxidative stress, inflammation, and tumor, and hence has been reported to be used in disease treatment (Chiu et al., 2021; Liu Y. et al., 2021; Lu et al., 2022). Tang et al. demonstrated that HKL inhibited the expression of NP cell apoptosis-related proteins induced by H2O2, the production of oxidative stress marker molecules, the level of inflammatory mediators, the expression of major extracellular matrix-degrading proteases, and then enhanced the expression of ECM anabolic proteins (Tang et al., 2018). The molecular mechanism of the action of HKL involves the inhibition of NF-κB/JNK signaling and TXNIP/NLRP3/caspase-1/IL-1β activation. SIRT3 is an important deacetylation modifying enzyme in mitochondria and is important for mitochondrial health. Wang et al. reported that HKL induced the upregulation of SIRT3 through the AMPK-PGC-1α axis, which improves the activity of antioxidant enzymes in mitochondria, and further prevents oxidative damage toNP cells (Wang et al., 2018b). In vivo experiments also confirmed the results of in vitro experiments. Therefore, HKL has the potential to treat IDD.

 Salvianolic Acid B

Salvia miltiorrhiza Bunge, also called Danshen, is atraditional Chinese herb. It has been used in Chinafor centuries (Wu et al., 2020; Xiao et al., 2020). Salvianolic acid B (SAB) is an abundant active ingredient from Danshen. SAB has been proved to have antioxidant (Zhao et al., 2019; Xiao et al., 2020) and anti-inflammatory activities (Ho and Hong, 2011). Dai et al. found that SAB slowed down the process of IDD and reconstructed the structure of IVD through in vivo experimental study. Subsequently, it was also confirmed that the levels of GSH and SOD2 in the degenerative IVD were reduced, and SAB treatment significantly reversed this change (Dai S. et al., 2021). In additional in vitro experiments, SAB was found to reduce the levels of ROS and MDA and increase the levels of GSH and SOD2. JAK2/STAT3 signaling pathway is suggested to be related to the antioxidant effect of SAB.

 Polydatin

Polydatin is the abundant form of resveratrol found in nature, and its average concentration in Polygonum cuspidatumandred wine is about 10times that of resveratrol (Liu W. et al., 2017). Polydatin, like resveratrol, has anti-inflammatory and antioxidant activities. It is worth noting that, unlike resveratrol, polydatin can enter cells through an active mechanism using glucose carriers and has a stronger anti-enzymatic oxidation ability than resveratrol. These properties allow polydatin to exhibit a higher absorption and better bioavailability relative to resveratrol (Tang, 2021). Wang et al. found that polydatin reduced the production of ROS through theNrf2 signaling pathway and protected rat NP cells from TNF-α-induced mitochondrial dysfunction and ECM degradation (Wang et al., 2018a). Moreover, Kang et al. found that polydatin upregulated Parkin and Nrf2 pathways, protecting CEP cells from H2O2-induced mitochondrial dysfunction, oxidative stress, and apoptosis, thereby inhibiting the development of IDD (Kang et al., 2020).

 Naringin

Naringin is a bioflavonoid found in the tangerine peel (Lavrador et al., 2018). It reportedly has a wide range of pharmacological activities, including antioxidant (Long et al., 2020; Bao et al., 2022) and anti-inflammatory effects (Zhao et al., 2020; Wu et al., 2021). Naringin has been confirmed to increase autophagy flux by activating the AMPK/SIRT1 pathway, thereby protecting NP cells from inflammatory response, oxidative stress, and impaired cellular homeostasis (Chen R. et al., 2022). Naringin can be developed into an effective drug to treat IDD.

 Baicalein

Baicalein is a flavonoid compound naturally found in the Chinese herb Scutellaria baicalensis. Baicalein possesses several pharmacological activities, including alleviation of inflammation (Wang X. et al., 2021; Jiang et al., 2022) and oxidative stress (Dai C. et al., 2021; Liu BY. et al., 2021). Baicalein helps treat IDD mainly via countering inflammation. It can inhibit NO, PGE2, TNF-α, and IL-6 induced by IL-1β (Jin et al., 2019). At the same time, it can reduce the expression of degrading enzymes MMP-13 and ADAMTS5 and upregulate the expression of aggrecan and type II collagen. A study examining its mechanism found that baicalein inhibited NF-κB and MAPK pathways. In vivo experiments also showed that baicalein could inhibit the process that led to IDD.

 Berberine

Berberine (BBR) is an isoquinoline alkaloid found in the long-used traditional Chinese herbs Rhizomacoptidis, Cortex Phellodendri, and Mahonia bealei. BBR reportedly has anti-inflammatory (Li Y. et al., 2022; Dai et al., 2022) and antioxidant properties (Cao et al., 2021; Seth et al., 2021). BBR has therapeutic effects on various diseases, including osteoarthritis. Its therapeutic potential in IDD has also been tested. Luo et al. demonstrated that BBR could inhibit oxidative stress-induced cell damage by regulating ER stress and autophagy (Luo et al., 2019). In vivo studies have also yielded similar evidence, suggesting that BBR treatment can delay the IVD destruction process induced by puncture in the rat model. Lu et al. found that BBR can inhibit the upregulation of NP extracellular matrix-degrading enzymes and the downregulation of the key components of the matrix, and excessive apoptosis induced by IL-1β (Lu et al., 2019).

 Genistein

Genistein is an isoflavone primarily identified in Glycine max (soybean) extract, among many other sources, such as peanuts, green peas, and legumes. Genistein reportedly prevents various diseases, such as anti-inflammatory, reducing osteoporosis, improving obesity, and anti-tumor (Fuloria et al., 2022; Goh et al., 2022; Ji et al., 2022). Wang et al. found that genistein can activate the Nrf2-mediated antioxidant defense system in NP cells (Wang et al., 2019) and subsequently inhibit TBHP-induced apoptosis and ECM degradation.

 Acacetin

Acacetin is a flavonoid compound from Saussurea involucrata plant and Damiana. Acacetin has been found to have anti-inflammatory (Ren et al., 2020; Singh et al., 2020), antioxidant (Song et al., 2022; Wu et al., 2022), anti-cancer (Wang S. et al., 2020; Yun et al., 2021), anti-osteoporosis (Jin et al., 2021; Lin et al., 2022), anti-diabetic (Han et al., 2020; Song et al., 2022) and other properties. Acacetin reportedly inhibits TBHP-induced ROS production by upregulating the expression of antioxidant proteins such as HO1, NQO1, and SOD in NP cells (Wang H. et al., 2020). Acacetin can also reduce the expression of inflammatory mediators such as COX-2 and iNOS induced by TBHP and also inhibits the degradation of extracellular matrix in NP cells. The activation of the Nrf2 pathway and the inhibition of the MAPK pathway are the specific mechanisms of the biological action of Acacetin. In vivo experiments also confirmed that Acacetin can reduce the process of IDD induced by puncture.

 Wogonin

Wogonin is an important flavonoid, isolated from the root of Scutellaria baicalensis Georgi (Chirumbolo, 2013). It has many pharmacological effects, including antioxidant and anti-inflammatory (Zheng et al., 2020; Feng et al., 2022; Shao et al., 2022). Fang et al. found that wogonin can inhibit IL-1β-induced inflammatory response and extracellular matrix degradation in NP cells (Fang et al., 2018). Further studies revealed that wogonin playsa key role by activating Nrf2/HO-1 pathway and inhibiting MAPK signaling pathway.

 Luteoloside

Luteoloside, a type of flavonoid glycoside, can be isolated from the plant Lonicera japonica (Xiong et al., 2013; Lin et al., 2019; Shi et al., 2020). It has recently been reported to possess anti-inflammatory and antibacterial properties. Lin et al. found that luteoloside inhibited IL-1β-induced the level of TNF-α, iNOS, NO, IL-6, COX-2, and PGE2 in rat NP cells (Lin et al., 2019). The level of apoptosis and ECM degradation were also improved by luteoloside (Lin et al., 2019). In addition, luteoloside has been proved to play a role by activating the Nrf2 pathway and then inhibiting the NF-κB pathway.

 Quercetin

Quercetin is a type of natural flavonoid isolated from various fruits and vegetables (Mirazimi et al., 2022). Previous studies have shown that quercetin possesses many functions, including anti-cancer, anti-oxidative, and anti-inflammatory properties (Pinheiro et al., 2021; Yin et al., 2021; Sun et al., 2022). Wang et al. found that quercetin can activate the autophagy pathway through SIRT1 so as to reduce the level of ROS and alleviate apoptosis and extracellular matrix degeneration (Wang D. et al., 2020). These findings hint at a new and effective treatment for IDD.

 Summary and Prospect

Oxidative stress and inflammation play an important role in the progression of IDD. Elevated levels of ROS and increased production of inflammatory cytokines in the degenerative discs can activate multiple signaling pathways that cause damage to IVD cells, resulting in structural damage and dysfunction of IVD, which in turn leads to the development of IDD (Johnson et al., 2015; Feng et al., 2017; Cao et al., 2022). Therefore, using oxidative stress and inflammation as therapeutic targets for IDD has wide-ranging prospects. In recent years, the research and application of phytochemicals have attracted significant attention. This review revealed that various phytochemicals could exert inhibitory effects on IDD based on the data from in vitro and in vivo experiments, mainly by inhibiting oxidative stress and inflammation. Also, given the cost-effectiveness and the availability of phytochemicals and their therapeutic role in IDD, research on the use of phytochemicals to improve IDD is rapidly increasing. Phytochemicals have emerged as an important source for developing therapeutic agents for IDD. Future research needs to consider several key points. The first is that phytochemicals can often have multiple targets; therefore, the synergistic effects between multiple signaling pathways and the broad range of cellular functions involved must be analyzed in an integrated manner when designing therapeutic agents for IDD to minimize side effects and expand therapeutic effects. Secondly, most of the research on the role of phytochemicals in IDD treatment is to deliver drugs to animals through IVD injection and other methods. However, very few studies have focused on the metabolism and distribution of phytochemicals in animals. Due to the extensive distribution of phytochemicals in animals, side effects may be encountered in other organs apart from the therapeutic effect on IDD. Exploring the panorama of the metabolic processes and organ distribution of phytochemicals in animals can help select appropriate phytochemicals and delivery methodsso as to improve the therapeutic efficacy of phytochemicals on IDD. Additionally, the dose of phytochemicals also needs to be focused upon in future studies. Currently, many in vitro experiments are focusing on the therapeutic effect and toxicity of different doses of phytochemicals on IDD models. In contrast, little attention is paid to the therapeutic effect of different doses and long-term toxicity to animals in vivo experiments. Therefore, in future studies, it may be necessary to perform multiple-dose in vivo experiments to verify its therapeutic effect so as to evaluate the effect of phytochemicals more comprehensively. Finally, although many studies have uncovered the favorable effects of phytochemicals for treating IDD, a large number of clinical trial studies are needed to further confirm their effects when applying them to the treatment of patients. Researchers and experts need to work together to develop a systematic experimental design and experimental analysis and establish an effective evaluation system to evaluate phytochemicals more safely and rationally and make these phytochemicals more effective in benefiting patients with IDD.

 Author Contributions

LK, RZ, and CS conceptualized the review. LK, HZ, CJ drafted the manuscript. LK, HZ, CJ, RZ, and CS revised and supplemented the manuscript. All the authors participated in writing and giving feedback on the manuscript. All authors have read and approved the final manuscript.

 Funding

This work was supported by the National Natural Science Foundation of China (No. 81772408).

 Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

 Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

 Abbreviations

LBP, low back pain; IVD, intervertebral disc; IDD, intervertebral disc degeneration; NP, nucleus pulposus; AF, annulus fibrosus; CEP, cartilage endplate; ECM, extracellular matrix; MMPs, matrix metalloproteinases; ADAMTS, a disintegrin and metalloprotease with thrombospondin motifs; VEGF, vascular endothelial growth factor; ROS, reactive oxygen species; AGEs, advanced glycation end products; CUR, curcumin; TBHP, Tert-butyl hydroperoxide; RES, resveratrol; EGCG, (-)-Epigallocatechin-3-gallate; CGA, chlorogenic acid; ICA, icariin; HKL, honokiol; SAB, salvianolic acid B; BBR, berberine.

 References Adams M. A. Roughley P. J. (2006). What Is Intervertebral Disc Degeneration, and what Causes it? Spine (Phila Pa 1976) 31 (18), 2151–2161. 10.1097/01.brs.0000231761.73859.2c Akter S. Moni A. Faisal G. M. Uddin M. R. Jahan N. Hannan M. A. (2022). Renoprotective Effects of Mangiferin: Pharmacological Advances and Future Perspectives. Ijerph 19 (3), 1864. 10.3390/ijerph19031864 Aswal S. Kumar A. Chauhan A. Semwal R. B. Kumar A. Semwal D. K. (2020). A Molecular Approach on the Protective Effects of Mangiferin against Diabetes and Diabetes-Related Complications. Curr. Diabetes Rev. 16 (7), 690–698. 10.2174/1573399815666191004112023 Bagdas D. Gul Z. Meade J. A. Cam B. Cinkilic N. Gurun M. S. (2020). Pharmacologic Overview of Chlorogenic Acid and its Metabolites in Chronic Pain and Inflammation. Curr. Neuropharmacol. 18 (3), 216–228. 10.2174/1570159x17666191021111809 Bai X. Ding W. Yang S. Guo X. (2019). Higenamine Inhibits IL-1β-induced Inflammation in Human Nucleus Pulposus Cells. Biosci. Rep. 39 (6). 10.1042/bsr20190857 Bao T. Yao J. Zhou S. Ma Y. Dong J. Zhang C. (2022). Naringin Prevents Follicular Atresia by Inhibiting Oxidative Stress in the Aging Chicken. Poult. Sci. 101 (7), 101891. 10.1016/j.psj.2022.101891 Bartels E. M. Fairbank J. C. Winlove C. P. Urban J. P. (1998). Oxygen and Lactate Concentrations Measured In Vivo in the Intervertebral Discs of Patients with Scoliosis and Back Pain. Spine (Phila Pa 1976) 23 (1), 1–8. ; discussion 8. 10.1097/00007632-199801010-00001 Bindu S. Mazumder S. Bandyopadhyay U. (2020). Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Organ Damage: A Current Perspective. Biochem. Pharmacol. 180, 114147. 10.1016/j.bcp.2020.114147 Butt M. S. Ahmad R. S. Sultan M. T. Qayyum M. M. Naz A. (2015). Green Tea and Anticancer Perspectives: Updates from Last Decade. Crit. Rev. Food Sci. Nutr. 55 (6), 792–805. 10.1080/10408398.2012.680205 Cai X. Yuan S. Zeng Y. Wang C. Yu N. Ding C. (2021). New Trends in Pharmacological Treatments for Osteoarthritis. Front. Pharmacol. 12. 10.3389/fphar.2021.645842 Cao G. Yang S. Cao J. Tan Z. Wu L. Dong F. (2022). The Role of Oxidative Stress in Intervertebral Disc Degeneration. Oxid. Med. Cell Longev. 2022, 2166817. 10.1155/2022/2166817 Cao R. Y. Zhang Y. Feng Z. Liu S. Liu Y. Zheng H. (2021). The Effective Role of Natural Product Berberine in Modulating Oxidative Stress and Inflammation Related Atherosclerosis: Novel Insights into the Gut-Heart Axis Evidenced by Genetic Sequencing Analysis. Front. Pharmacol. 12, 764994. 10.3389/fphar.2021.764994 Cháirez-Ramírez M. H. de la Cruz-López K. G. García-Carrancá A. (2021). Polyphenols as Antitumor Agents Targeting Key Players in Cancer-Driving Signaling Pathways. Front. Pharmacol. 12, 710304. 10.3389/fphar.2021.710304 Chen C. Yu L.-T. Cheng B.-R. Xu J.-L. Cai Y. Jin J.-L. (2022a). Promising Therapeutic Candidate for Myocardial Ischemia/Reperfusion Injury: What Are the Possible Mechanisms and Roles of Phytochemicals? Front. Cardiovasc. Med. 8. 10.3389/fcvm.2021.792592 Chen D. Huang C. Chen Z. (2019). A Review for the Pharmacological Effect of Lycopene in Central Nervous System Disorders. Biomed. Pharmacother. 111, 791–801. 10.1016/j.biopha.2018.12.151 Chen G. Song X. Lin D. Xu P. (2020). Isofraxidin Alleviates Myocardial Infarction through NLRP3 Inflammasome Inhibition. Inflammation 43 (2), 712–721. 10.1007/s10753-019-01158-z Chen H. W. Zhang G. Z. Liu M. Q. Zhang L. J. Kang J. H. Wang Z. H. (2021). Natural Products of Pharmacology and Mechanisms in Nucleus Pulposus Cells and Intervertebral Disc Degeneration. Evid. Based Complement. Altern. Med. 2021, 9963677. 10.1155/2021/9963677 Chen J. Xuan J. Gu Y. T. Shi K. S. Xie J. J. Chen J. X. (2017). Celastrol Reduces IL-1β Induced Matrix Catabolism, Oxidative Stress and Inflammation in Human Nucleus Pulposus Cells and Attenuates Rat Intervertebral Disc Degeneration In Vivo . Biomed. Pharmacother. 91, 208–219. 10.1016/j.biopha.2017.04.093 Chen J. W. Ni B. B. Li B. Yang Y. H. Jiang S. D. Jiang L. S. (2014). The Responses of Autophagy and Apoptosis to Oxidative Stress in Nucleus Pulposus Cells: Implications for Disc Degeneration. Cell Physiol. Biochem. 34 (4), 1175–1189. 10.1159/000366330 Chen J. W. Ni B. B. Zheng X. F. Li B. Jiang S. D. Jiang L. S. (2015). Hypoxia Facilitates the Survival of Nucleus Pulposus Cells in Serum Deprivation by Down-Regulating Excessive Autophagy through Restricting ROS Generation. Int. J. Biochem. Cell Biol. 59, 1–10. 10.1016/j.biocel.2014.11.009 Chen R. Gao S. Guan H. Zhang X. Gao Y. Su Y. (2022b). Naringin Protects Human Nucleus Pulposus Cells against TNF-α-Induced Inflammation, Oxidative Stress, and Loss of Cellular Homeostasis by Enhancing Autophagic Flux via AMPK/SIRT1 Activation. Oxidative Med. Cell. Longev. 2022, 7655142. 10.1155/2022/7655142 Chirumbolo S. (2013). Anticancer Properties of the Flavone Wogonin. Toxicology 314 (1), 60–64. 10.1016/j.tox.2013.08.016 Chiu K. C. Shih Y. H. Wang T. H. Lan W. C. Li P. J. Jhuang H. S. (2021). In Vitro antimicrobial and Antipro-Inflammation Potential of Honokiol and Magnolol against Oral Pathogens and Macrophages. J. Formos. Med. Assoc. 120 (2), 827–837. 10.1016/j.jfma.2020.09.002 Conaghan P. G. (2012). A Turbulent Decade for NSAIDs: Update on Current Concepts of Classification, Epidemiology, Comparative Efficacy, and Toxicity. Rheumatol. Int. 32 (6), 1491–1502. 10.1007/s00296-011-2263-6 Dai C. Li H. Wang Y. Tang S. Velkov T. Shen J. (2021a). Inhibition of Oxidative Stress and ALOX12 and NF-Κb Pathways Contribute to the Protective Effect of Baicalein on Carbon Tetrachloride-Induced Acute Liver Injury. Antioxidants (Basel) 10 (6). 10.3390/antiox10060976 Dai L. Zhu L. Ma S. Liu J. Zhang M. Li J. (2022). Berberine Alleviates NLRP3 Inflammasome Induced Endothelial Junction Dysfunction through Ca2+ Signalling in Inflammatory Vascular Injury. Phytomedicine 101, 154131. 10.1016/j.phymed.2022.154131 Dai S. Liang T. Shi X. Luo Z. Yang H. (2021b). Salvianolic Acid B Protects Intervertebral Discs from Oxidative Stress-Induced Degeneration via Activation of the JAK2/STAT3 Signaling Pathway. Oxidative Med. Cell. Longev. 2021, 6672978. 10.1155/2021/6672978 Dalibalta S. Majdalawieh A. F. Manjikian H. (2020). Health Benefits of Sesamin on Cardiovascular Disease and its Associated Risk Factors. Saudi Pharm. J. 28 (10), 1276–1289. 10.1016/j.jsps.2020.08.018 Deng J. Zong Z. Su Z. Chen H. Huang J. Niu Y. (2021). Recent Advances in Pharmacological Intervention of Osteoarthritis: A Biological Aspect. Front. Pharmacol. 12. 10.3389/fphar.2021.772678 Deng Z. Li Y. Liu H. Xiao S. Li L. Tian J. (2019). The Role of Sirtuin 1 and its Activator, Resveratrol in Osteoarthritis. Biosci. Rep. 39 (5). 10.1042/bsr20190189 Dimozi A. Mavrogonatou E. Sklirou A. Kletsas D. (2015). Oxidative Stress Inhibits the Proliferation, Induces Premature Senescence and Promotes a Catabolic Phenotype in Human Nucleus Pulposus Intervertebral Disc Cells. Eur. Cell Mater 30, 89–103. discussion 103. 10.22203/ecm.v030a07 Ding F. Shao Z. W. Xiong L. M. (2013). Cell Death in Intervertebral Disc Degeneration. Apoptosis 18 (7), 777–785. 10.1007/s10495-013-0839-1 Dowdell J. Erwin M. Choma T. Vaccaro A. Iatridis J. Cho S. K. (2017). Intervertebral Disk Degeneration and Repair. Neurosurgery 80 (3s), S46–s54. 10.1093/neuros/nyw078 Fan F. Lei M. (2022). Mechanisms Underlying Curcumin-Induced Neuroprotection in Cerebral Ischemia. Front. Pharmacol. 13, 893118. 10.3389/fphar.2022.893118 Fang W. Zhou X. Wang J. Xu L. Zhou L. Yu W. (2018). Wogonin Mitigates Intervertebral Disc Degeneration through the Nrf2/ARE and MAPK Signaling Pathways. Int. Immunopharmacol. 65, 539–549. 10.1016/j.intimp.2018.10.024 Farabegoli F. Pinheiro M. (2022). Epigallocatechin-3-Gallate Delivery in Lipid-Based Nanoparticles: Potentiality and Perspectives for Future Applications in Cancer Chemoprevention and Therapy. Front. Pharmacol. 13, 809706. 10.3389/fphar.2022.809706 Feng C. Yang M. Lan M. Liu C. Zhang Y. Huang B. (2017). ROS: Crucial Intermediators in the Pathogenesis of Intervertebral Disc Degeneration. Oxid. Med. Cell Longev. 2017, 5601593. 10.1155/2017/5601593 Feng Y. Ju Y. Yan Z. Ji M. Yang M. Wu Q. (2022). Protective Role of Wogonin Following Traumatic Brain Injury by Reducing Oxidative Stress and Apoptosis via the PI3K/Nrf2/HO-1 P-athway. Int. J. Mol. Med. 49 (4). 10.3892/ijmm.2022.5109 Filomeni G. De Zio D. Cecconi F. (2015). Oxidative Stress and Autophagy: the Clash between Damage and Metabolic Needs. Cell Death Differ. 22 (3), 377–388. 10.1038/cdd.2014.150 Francisco V. Pino J. González-Gay M. Á. Lago F. Karppinen J. Tervonen O. (2022). A New Immunometabolic Perspective of Intervertebral Disc Degeneration. Nat. Rev. Rheumatol. 18 (1), 47–60. 10.1038/s41584-021-00713-z Freemont A. J. (2009). The Cellular Pathobiology of the Degenerate Intervertebral Disc and Discogenic Back Pain. Rheumatol. Oxf. 48 (1), 5–10. 10.1093/rheumatology/ken396 Freemont A. J. Watkins A. Le Maitre C. Baird P. Jeziorska M. Knight M. T. (2002). Nerve Growth Factor Expression and Innervation of the Painful Intervertebral Disc. J. Pathol. 197 (3), 286–292. 10.1002/path.1108 Fuloria S. Yusri M. A. A. Sekar M. Gan S. H. Rani N. N. I. M. Lum P. T. (2022). Genistein: A Potential Natural Lead Molecule for New Drug Design and Development for Treating Memory Impairment. Molecules 27 (1), 265. 10.3390/molecules27010265 Ge Q. Ying J. Shi Z. Mao Q. Jin H. Wang P. E. (2021). Chlorogenic Acid Retards Cartilaginous Endplate Degeneration and Ameliorates Intervertebral Disc Degeneration via Suppressing NF-Κb Signaling. Life Sci. 274, 119324. 10.1016/j.lfs.2021.119324 Gille L. Nohl H. (2001). The Ubiquinol/bc1 Redox Couple Regulates Mitochondrial Oxygen Radical Formation. Arch. Biochem. Biophys. 388 (1), 34–38. 10.1006/abbi.2000.2257 Goh Y. X. Jalil J. Lam K. W. Husain K. Premakumar C. M. (2022). Genistein: A Review on its Anti-inflammatory Properties. Front. Pharmacol. 13, 820969. 10.3389/fphar.2022.820969 Guangtao F. Zhenkang W. Zhantao D. Mengyuan L. Qingtian L. Yuanchen M. (2021). Icariin Alleviates Wear Particle-Induced Periprosthetic Osteolysis via Down-Regulation of the Estrogen Receptor α-mediated NF-Κb Signaling Pathway in Macrophages. Front. Pharmacol. 12, 746391. 10.3389/fphar.2021.746391 Ha Y. M. Kim M. Y. Park M. K. Lee Y. S. Kim Y. M. Kim H. J. (2012). Higenamine Reduces HMGB1 during Hypoxia-Induced Brain Injury by Induction of Heme Oxygenase-1 through PI3K/Akt/Nrf-2 Signal Pathways. Apoptosis 17 (5), 463–474. 10.1007/s10495-011-0688-8 Han W. M. Chen X. C. Li G. R. Wang Y. (2020). Acacetin Protects against High Glucose-Induced Endothelial Cells Injury by Preserving Mitochondrial Function via Activating Sirt1/Sirt3/AMPK Signals. Front. Pharmacol. 11, 607796. 10.3389/fphar.2020.607796 Ho J. H. Hong C. Y. (2011). Salvianolic Acids: Small Compounds with Multiple Mechanisms for Cardiovascular Protection. J. Biomed. Sci. 18 (1), 30. 10.1186/1423-0127-18-30 Hua W. Li S. Luo R. Wu X. Zhang Y. Liao Z. (2020). Icariin Protects Human Nucleus Pulposus Cells from Hydrogen Peroxide-Induced Mitochondria-Mediated Apoptosis by Activating Nuclear Factor Erythroid 2-related Factor 2. Biochim. Biophys. Acta Mol. Basis Dis. 1866 (1), 165575. 10.1016/j.bbadis.2019.165575 Hua W. Zhang Y. Wu X. Kang L. Tu J. Zhao K. (2018). Icariin Attenuates Interleukin-1β-Induced Inflammatory Response in Human Nucleus Pulposus Cells. Curr. Pharm. Des. 23 (39), 6071–6078. 10.2174/1381612823666170615112158 Huang J. Zheng L. Wang F. Su Y. Kong H. Xin H. (2020). Mangiferin Ameliorates Placental Oxidative Stress and Activates PI3K/Akt/mTOR Pathway in Mouse Model of Preeclampsia. Arch. Pharm. Res. 43 (2), 233–241. 10.1007/s12272-020-01220-7 Imran M. Ghorat F. Ul-Haq I. Ur-Rehman H. Aslam F. Heydari M. (2020). Lycopene as a Natural Antioxidant Used to Prevent Human Health Disorders. Antioxidants (Basel) 9 (8). 10.3390/antiox9080706 Ismail M. B. Rajendran P. AbuZahra H. M. Veeraraghavan V. P. (2021). Mangiferin Inhibits Apoptosis in Doxorubicin-Induced Vascular Endothelial Cells via the Nrf2 Signaling Pathway. Ijms 22 (8), 4259. 10.3390/ijms22084259 Izzo C. Annunziata M. Melara G. Sciorio R. Dallio M. Masarone M. (2021). The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials. Nutrients 13 (3). 10.3390/nu13030933 Ji X. Liu K. Li Q. Shen Q. Han F. Ye Q. (2022). A Mini-Review of Flavone Isomers Apigenin and Genistein in Prostate Cancer Treatment. Front. Pharmacol. 13, 851589. 10.3389/fphar.2022.851589 Jia J. Nie L. Liu Y. (2020). Butyrate Alleviates Inflammatory Response and NF-Κb Activation in Human Degenerated Intervertebral Disc Tissues. Int. Immunopharmacol. 78, 106004. 10.1016/j.intimp.2019.106004 Jiang C. Zhang J. Xie H. Guan H. Li R. Chen C. (2022). Baicalein Suppresses Lipopolysaccharide-Induced Acute Lung Injury by Regulating Drp1-dependent Mitochondrial Fission of Macrophages. Biomed. Pharmacother. 145, 112408. 10.1016/j.biopha.2021.112408 Jimbo K. Park J. S. Yokosuka K. Sato K. Nagata K. (2005). Positive Feedback Loop of Interleukin-1beta Upregulating Production of Inflammatory Mediators in Human Intervertebral Disc Cells In Vitro . J. Neurosurg. Spine 2 (5), 589–595. 10.3171/spi.2005.2.5.0589 Jin H. Wang Q. Wu J. Han X. Qian T. Zhang Z. (2019). Baicalein Inhibits the IL-1β-Induced Inflammatory Response in Nucleus Pulposus Cells and Attenuates Disc Degeneration In Vivo . Inflammation 42 (3), 1032–1044. 10.1007/s10753-019-00965-8 Jin M. Nie J. Zhu J. Li J. Fang T. Xu J. (2021). Acacetin Inhibits RANKL-Induced Osteoclastogenesis and LPS-Induced Bone Loss by Modulating NFATc1 Transcription. Biochem. Biophys. Res. Commun. 583, 146–153. 10.1016/j.bbrc.2021.10.066 Jin T. Zhang Y. Botchway B. O. A. Zhang J. Fan R. Zhang Y. (2022). Curcumin Can Improve Parkinson's Disease via Activating BDNF/PI3k/Akt Signaling Pathways. Food Chem. Toxicol. 164, 113091. 10.1016/j.fct.2022.113091 Jing M. Yang J. Zhang L. Liu J. Xu S. Wang M. (2021). Celastrol Inhibits Rheumatoid Arthritis through the ROS-NF-Κb-NLRP3 Inflammasome axis. Int. Immunopharmacol. 98, 107879. 10.1016/j.intimp.2021.107879 Johnson W. E. Evans H. Menage J. Eisenstein S. M. El Haj A. Roberts S. (2001). Immunohistochemical Detection of Schwann Cells in Innervated and Vascularized Human Intervertebral Discs. Spine (Phila Pa 1976) 26 (23), 2550–2557. 10.1097/00007632-200112010-00007 Johnson Z. I. Schoepflin Z. R. Choi H. Shapiro I. M. Risbud M. V. (2015). Disc in Flames: Roles of TNF-α and IL-1β in Intervertebral Disc Degeneration. Eur. Cell Mater 30, 104–107. ; discussion 116-107. 10.22203/ecm.v030a08 Kang L. Liu S. Li J. Tian Y. Xue Y. Liu X. (2020). Parkin and Nrf2 Prevent Oxidative Stress-Induced Apoptosis in Intervertebral Endplate Chondrocytes via Inducing Mitophagy and Anti-oxidant Defenses. Life Sci. 243, 117244. 10.1016/j.lfs.2019.117244 Kang L. Xiang Q. Zhan S. Song Y. Wang K. Zhao K. (2019). Restoration of Autophagic Flux Rescues Oxidative Damage and Mitochondrial Dysfunction to Protect against Intervertebral Disc Degeneration. Oxid. Med. Cell Longev. 2019, 7810320. 10.1155/2019/7810320 Kim K. A. Yim J. E. (2015). Antioxidative Activity of Onion Peel Extract in Obese Women: A Randomized, Double-Blind, Placebo Controlled Study. J. Cancer Prev. 20 (3), 202–207. 10.15430/jcp.2015.20.3.202 Kwon W. K. Moon H. J. Kwon T. H. Park Y. K. Kim J. H. (2017). The Role of Hypoxia in Angiogenesis and Extracellular Matrix Regulation of Intervertebral Disc Cells during Inflammatory Reactions. Neurosurgery 81 (5), 867–875. 10.1093/neuros/nyx149 Kzhyshkowska J. (2022). Stabilizing the Immune System by Chlorogenic Acid. J. Leukoc. Bio. 10.1002/jlb.3ce0821-427rr Lau K. K. L. Samartzis D. To N. S. C. Harada G. K. An H. S. Wong A. Y. L. (2021). Demographic, Surgical, and Radiographic Risk Factors for Symptomatic Adjacent Segment Disease after Lumbar Fusion: A Systematic Review and Meta-Analysis. J. Bone Jt. Surg. 103 (15). 10.2106/jbjs.20.00408 Lavrador P. Gaspar V. M. Mano J. F. (2018). Bioinspired Bone Therapies Using Naringin: Applications and Advances. Drug Discov. Today 23 (6), 1293–1304. 10.1016/j.drudis.2018.05.012 Le Maitre C. L. Pockert A. Buttle D. J. Freemont A. J. Hoyland J. A. (2007). Matrix Synthesis and Degradation in Human Intervertebral Disc Degeneration. Biochem. Soc. Trans. 35 (Pt 4), 652–655. 10.1042/bst0350652 Lee D. C. Adams C. S. Albert T. J. Shapiro I. M. Evans S. M. Koch C. J. (2007). In Situ oxygen Utilization in the Rat Intervertebral Disc. J. Anat. 210 (3), 294–303. 10.1111/j.1469-7580.2007.00692.x Li K. Li Y. Mi J. Mao L. Han X. Zhao J. (2018). Resveratrol Protects against Sodium Nitroprusside Induced Nucleus Pulposus Cell Apoptosis by Scavenging ROS. Int. J. Mol. Med. 41 (5), 2485–2492. 10.3892/ijmm.2018.3461 Li K. Li Y. Xu B. Mao L. Zhao J. (2016). Sesamin Inhibits Lipopolysaccharide-Induced Inflammation and Extracellular Matrix Catabolism in Rat Intervertebral Disc. Connect. Tissue Res. 57 (5), 347–359. 10.1080/03008207.2016.1182998 Li K. Lv C. (2020). Intradiscal Injection of Sesamin Protects from Lesion-Induced Degeneration. Connect. Tissue Res. 61 (6), 594–603. 10.1080/03008207.2019.1651847 Li K. X. Ji M. J. Sun H. J. (2021a). An Updated Pharmacological Insight of Resveratrol in the Treatment of Diabetic Nephropathy. Gene 780, 145532. 10.1016/j.gene.2021.145532 Li K. X. Wang Z. C. Machuki J. O. Li M. Z. Wu Y. J. Niu M. K. (2022a). Benefits of Curcumin in the Vasculature: A Therapeutic Candidate for Vascular Remodeling in Arterial Hypertension and Pulmonary Arterial Hypertension? Front. Physiol. 13, 848867. 10.3389/fphys.2022.848867 Li M. Xie F. Wang L. Zhu G. Qi L.-W. Jiang S. (2022b). Celastrol: An Update on its Hepatoprotective Properties and the Linked Molecular Mechanisms. Front. Pharmacol. 13, 857956. 10.3389/fphar.2022.857956 Li N. Xiong R. He R. Liu B. Wang B. Geng Q. (2021b). Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation. J. Inflamm. Res. 14, 2289–2300. 10.2147/jir.s304492 Li Y. Wu Y. Jiang K. Han W. Zhang J. Xie L. (2019). Mangiferin Prevents TBHP-Induced Apoptosis and ECM Degradation in Mouse Osteoarthritic Chondrocytes via Restoring Autophagy and Ameliorates Murine Osteoarthritis. Oxid. Med. Cell Longev. 2019, 8783197. 10.1155/2019/8783197 Li Y. Chen X. Chen Y. Yu D. Jiang R. Kou X. (2022c). Berberine Improves TNF-α-Induced Hepatic Insulin Resistance by Targeting MEKK1/MEK Pathway. Inflammation. 10.1007/s10753-022-01671-8 Liang N. Kitts D. D. (2015). Role of Chlorogenic Acids in Controlling Oxidative and Inflammatory Stress Conditions. Nutrients 8 (1). 10.3390/nu8010016 Lin J. Chen J. Zhang Z. Xu T. Shao Z. Wang X. (2019). Luteoloside Inhibits IL-1β-Induced Apoptosis and Catabolism in Nucleus Pulposus Cells and Ameliorates Intervertebral Disk Degeneration. Front. Pharmacol. 10, 868. 10.3389/fphar.2019.00868 Lin J. Li X. Qi W. Yan Y. Chen K. Xue X. (2018). Isofraxidin Inhibits Interleukin-1β Induced Inflammatory Response in Human Osteoarthritis Chondrocytes. Int. Immunopharmacol. 64, 238–245. 10.1016/j.intimp.2018.09.003 Lin X. Xu F. Zhang K.-W. Qiu W.-X. Zhang H. Hao Q. (2022). Acacetin Prevents Bone Loss by Disrupting Osteoclast Formation and Promoting Type H Vessel Formation in Ovariectomy-Induced Osteoporosis. Front. Cell Dev. Biol. 10, 796227. 10.3389/fcell.2022.796227 Liu B. Y. Li L. Liu G. L. Ding W. Chang W. G. Xu T. (2021a). Baicalein Attenuates Cardiac Hypertrophy in Mice via Suppressing Oxidative Stress and Activating Autophagy in Cardiomyocytes. Acta Pharmacol. Sin. 42 (5), 701–714. 10.1038/s41401-020-0496-1 Liu S. Sun Z. Chu P. Li H. Ahsan A. Zhou Z. (2017a). EGCG Protects against Homocysteine-Induced Human Umbilical Vein Endothelial Cells Apoptosis by Modulating Mitochondrial-dependent Apoptotic Signaling and PI3K/Akt/eNOS Signaling Pathways. Apoptosis 22 (5), 672–680. 10.1007/s10495-017-1360-8 Liu W. Chen P. Deng J. Lv J. Liu J. (2017b). Resveratrol and Polydatin as Modulators of Ca2+ Mobilization in the Cardiovascular System. Ann. N. Y. Acad. Sci. 1403 (1), 82–91. 10.1111/nyas.13386 Liu X. J. Lv Y. F. Cui W. Z. Li Y. Liu Y. Xue Y. T. (2021b). Icariin Inhibits Hypoxia/reoxygenation-Induced Ferroptosis of Cardiomyocytes via Regulation of the Nrf2/HO-1 Signaling Pathway. FEBS open bio 11 (11), 2966–2976. 10.1002/2211-5463.13276 Liu Y. Zhou J. Luo Y. Li J. Shang L. Zhou F. (2021c). Honokiol Alleviates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis via Nrf2 Activation In Vitro and In Vivo . Chin. Med. 16 (1), 127. 10.1186/s13020-021-00541-z Long J. Y. Chen J. M. Liao Y. J. Zhou Y. J. Liang B. Y. Zhou Y. (2020). Naringin Provides Neuroprotection in CCL2-Induced Cognition Impairment by Attenuating Neuronal Apoptosis in the hippocampus. Behav. Brain Funct. 16 (1), 4. 10.1186/s12993-020-00166-6 Lu L. Hu J. Wu Q. An Y. Cui W. Wang J. (2019). Berberine Prevents Human Nucleus Pulposus Cells from IL-1β-induced E-xtracellular M-atrix D-egradation and A-poptosis by I-nhibiting the NF-κB P-athway. Int. J. Mol. Med. 43 (4), 1679–1686. 10.3892/ijmm.2019.4105 Lu X. Lu X. Yang P. Zhang Z. Lv H. (2022). Honokiol Nanosuspensions Loaded Thermosensitive Hydrogels as the Local Delivery System in Combination with Systemic Paclitaxel for Synergistic Therapy of Breast Cancer. Eur. J. Pharm. Sci. 175, 106212. 10.1016/j.ejps.2022.106212 Lu Y. Zhou L. He S. Ren H. L. Zhou N. Hu Z. M. (2020). Lycopene Alleviates Disc Degeneration under Oxidative Stress through the Nrf2 Signaling Pathway. Mol. Cell Probes 51, 101559. 10.1016/j.mcp.2020.101559 Lum P. T. Sekar M. Gan S. H. Jeyabalan S. Bonam S. R. Rani N. N. I. M. (2022). Therapeutic Potential of Mangiferin against Kidney Disorders and its Mechanism of Action: A Review. Saudi J. Biol. Sci. 29 (3), 1530–1542. 10.1016/j.sjbs.2021.11.016 Luo R. Liao Z. Song Y. Yin H. Zhan S. Li G. (2019). Berberine Ameliorates Oxidative Stress-Induced Apoptosis by Modulating ER Stress and Autophagy in Human Nucleus Pulposus Cells. Life Sci. 228, 85–97. 10.1016/j.lfs.2019.04.064 Ma Y. Liu G. Tang M. Fang J. Jiang H. (2021). Epigallocatechin Gallate Can Protect Mice from Acute Stress Induced by LPS while Stabilizing Gut Microbes and Serum Metabolites Levels. Front. Immunol. 12, 640305. 10.3389/fimmu.2021.640305 Majdalawieh A. F. Massri M. Nasrallah G. K. (2017). A Comprehensive Review on the Anti-cancer Properties and Mechanisms of Action of Sesamin, a Lignan in Sesame Seeds (Sesamum indicum). Eur. J. Pharmacol. 815, 512–521. 10.1016/j.ejphar.2017.10.020 Majnooni M. B. Fakhri S. Shokoohinia Y. Mojarrab M. Kazemi-Afrakoti S. Farzaei M. H. (2020). Isofraxidin: Synthesis, Biosynthesis, Isolation, Pharmacokinetic and Pharmacological Properties. Molecules 25 (9). 10.3390/molecules25092040 Mirazimi S. M. A. Dashti F. Tobeiha M. Shahini A. Jafari R. Khoddami M. (2022). Application of Quercetin in the Treatment of Gastrointestinal Cancers. Front. Pharmacol. 13, 860209. 10.3389/fphar.2022.860209 Mobasheri A. Henrotin Y. Biesalski H. K. Shakibaei M. (2012). Scientific Evidence and Rationale for the Development of Curcumin and Resveratrol as Nutraceutricals for Joint Health. Int. J. Mol. Sci. 13 (4), 4202–4232. 10.3390/ijms13044202 Morozkina S. N. Nhung Vu T. H. Generalova Y. E. Snetkov P. P. Uspenskaya M. V. (2021). Mangiferin as New Potential Anti-cancer Agent and Mangiferin-Integrated Polymer Systems-A Novel Research Direction. Biomolecules 11 (1). 10.3390/biom11010079 Mozos I. Stoian D. Caraba A. Malainer C. Horbańczuk J. O. Atanasov A. G. (2018). Lycopene and Vascular Health. Front. Pharmacol. 9, 521. 10.3389/fphar.2018.00521 Müller L. Caris-Veyrat C. Lowe G. Böhm V. (2016). Lycopene and its Antioxidant Role in the Prevention of Cardiovascular Diseases-A Critical Review. Crit. Rev. Food Sci. Nutr. 56 (11), 1868–1879. 10.1080/10408398.2013.801827 Nguyen C. Savouret J. F. Widerak M. Corvol M. T. Rannou F. (2017). Resveratrol, Potential Therapeutic Interest in Joint Disorders: A Critical Narrative Review. Nutrients 9 (1). 10.3390/nu9010045 Noor Mohammadi T. Maung A. T. Sato J. Sonoda T. Masuda Y. Honjoh K. (2019). Mechanism for Antibacterial Action of Epigallocatechin Gallate and Theaflavin-3,3'-Digallate on Clostridium perfringens . J. Appl. Microbiol. 126 (2), 633–640. 10.1111/jam.14134 Nwafor E. O. Lu P. Zhang Y. Liu R. Peng H. Xing B. (2022). Chlorogenic Acid: Potential Source of Natural Drugs for the Therapeutics of Fibrosis and Cancer. Transl. Oncol. 15 (1), 101294. 10.1016/j.tranon.2021.101294 Ohtori S. Miyagi M. Eguchi Y. Inoue G. Orita S. Ochiai N. (2012a). Efficacy of Epidural Administration of Anti-interleukin-6 Receptor Antibody onto Spinal Nerve for Treatment of Sciatica. Eur. Spine J. 21 (10), 2079–2084. official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 10.1007/s00586-012-2183-5 Ohtori S. Miyagi M. Eguchi Y. Inoue G. Orita S. Ochiai N. (2012b). Epidural Administration of Spinal Nerves with the Tumor Necrosis Factor-Alpha Inhibitor, Etanercept, Compared with Dexamethasone for Treatment of Sciatica in Patients with Lumbar Spinal Stenosis: a Prospective Randomized Study. Spine (Phila Pa 1976) 37 (6), 439–444. 10.1097/BRS.0b013e318238af83 Oichi T. Taniguchi Y. Oshima Y. Tanaka S. Saito T. (2020). Pathomechanism of Intervertebral Disc Degeneration. JOR Spine 3 (1), e1076. 10.1002/jsp2.1076 Ojo O. A. Adeyemo T. R. Rotimi D. Batiha G. E. Mostafa-Hedeab G. Iyobhebhe M. E. (2022). Anticancer Properties of Curcumin against Colorectal Cancer: A Review. Front. Oncol. 12, 881641. 10.3389/fonc.2022.881641 Orita S. Ohtori S. Nagata M. Horii M. Yamashita M. Yamauchi K. (2010). Inhibiting Nerve Growth Factor or its Receptors Downregulates Calcitonin Gene-Related Peptide Expression in Rat Lumbar Dorsal Root Ganglia Innervating Injured Intervertebral Discs. J. Orthop. Res. 28 (12), 1614–1620. 10.1002/jor.21170 Park D. H. Park J. Y. Kang K. S. Hwang G. S. (2021). Neuroprotective Effect of Gallocatechin Gallate on Glutamate-Induced Oxidative Stress in Hippocampal HT22 Cells. Molecules 26 (5), 1387. 10.3390/molecules26051387 Pinheiro R. G. R. Pinheiro M. Neves A. R. (2021). Nanotechnology Innovations to Enhance the Therapeutic Efficacy of Quercetin. Nanomaterials 11 (10), 2658. 10.3390/nano11102658 Prasad R. Katiyar S. K. (2016). Honokiol, an Active Compound of Magnolia Plant, Inhibits Growth, and Progression of Cancers of Different Organs. Adv. Exp. Med. Biol. 928, 245–265. 10.1007/978-3-319-41334-1_11 Qu Y. Zhou L. Wang C. (2017). Mangiferin Inhibits IL-1β-Induced Inflammatory Response by Activating PPAR-γ in Human Osteoarthritis Chondrocytes. Inflammation 40 (1), 52–57. 10.1007/s10753-016-0451-y Ren J. Yue B. Wang H. Zhang B. Luo X. Yu Z. (2020). Acacetin Ameliorates Experimental Colitis in Mice via Inhibiting Macrophage Inflammatory Response and Regulating the Composition of Gut Microbiota. Front. Physiol. 11, 577237. 10.3389/fphys.2020.577237 Reuter S. Gupta S. C. Chaturvedi M. M. Aggarwal B. B. (2010). Oxidative Stress, Inflammation, and Cancer: How Are They Linked? Free Radic. Biol. Med. 49 (11), 1603–1616. 10.1016/j.freeradbiomed.2010.09.006 Romeo I. Parise A. Galano A. Russo N. Alvarez-Idaboy J. R. Marino T. (2020). The Antioxidant Capability of Higenamine: Insights from Theory. Antioxidants (Basel) 9 (5). 10.3390/antiox9050358 Samadarsi R. Dutta D. (2020). Anti-oxidative Effect of Mangiferin-Chitosan Nanoparticles on Oxidative Stress-Induced Renal Cells. Int. J. Biol. Macromol. 151, 36–46. 10.1016/j.ijbiomac.2020.02.112 Seth E. Ahsan A. U. Kaushal S. Mehra S. Chopra M. (2021). Berberine Affords Protection against Oxidative Stress and Apoptotic Damage in F1 Generation of Wistar Rats Following Lactational Exposure to Chlorpyrifos. Pestic. Biochem. Physiol. 179, 104977. 10.1016/j.pestbp.2021.104977 Shao W. Zhang C. Li K. Lu Z. Zhao Z. Gao K. (2022). Wogonin Inhibits Inflammation and Apoptosis through STAT3 Signal Pathway to Promote the Recovery of Spinal Cord Injury. Brain Res. 1782, 147843. 10.1016/j.brainres.2022.147843 Shi C. Y. He X. B. Zhao C. Wang H. J. (2020). Luteoloside Exerts Analgesic Effect in a Complete Freund's Adjuvant-Induced Inflammatory Model via Inhibiting Interleukin-1β Expression and Macrophage/Microglia Activation. Front. Pharmacol. 11, 1158. 10.3389/fphar.2020.01158 Singh S. Gupta P. Meena A. Luqman S. (2020). Acacetin, a Flavone with Diverse Therapeutic Potential in Cancer, Inflammation, Infections and Other Metabolic Disorders. Food Chem. Toxicol. 145, 111708. 10.1016/j.fct.2020.111708 Song F. Mao Y. J. Hu Y. Zhao S. S. Wang R. Wu W. Y. (2022). Acacetin Attenuates Diabetes-Induced Cardiomyopathy by Inhibiting Oxidative Stress and Energy Metabolism via PPAR-α/AMPK Pathway. Eur. J. Pharmacol. 922, 174916. 10.1016/j.ejphar.2022.174916 Song Y. Li S. Geng W. Luo R. Liu W. Tu J. (2018). Sirtuin 3-dependent Mitochondrial Redox Homeostasis Protects against AGEs-Induced Intervertebral Disc Degeneration. Redox Biol. 19, 339–353. 10.1016/j.redox.2018.09.006 Song Y. Wang Y. Zhang Y. Geng W. Liu W. Gao Y. (2017). Advanced Glycation End Products Regulate Anabolic and Catabolic Activities via NLRP3-Inflammasome Activation in Human Nucleus Pulposus Cells. J. Cell Mol. Med. 21 (7), 1373–1387. 10.1111/jcmm.13067 Su X. Liu B. Gong F. Yin J. Sun Q. Gao Y. (2019). Isofraxidin Attenuates IL-1β-induced Inflammatory Response in Human Nucleus Pulposus Cells. J. Cell Biochem. 120 (8), 13302–13309. 10.1002/jcb.28604 Sun L. Guo L. Xu G. Li Z. Appiah M. O. Yang L. (2022). Quercetin Reduces Inflammation and Protects Gut Microbiota in Broilers. Molecules 27 (10), 3269. 10.3390/molecules27103269 Tang K. S. (2020). Protective Effects of Polydatin against Dementia-Related Disorders. Curr. Neuropharmacol. 19 (2), 127–135. 10.2174/1570159x18666200611144825 Tang P. Gu J. M. Xie Z. A. Gu Y. Jie Z. W. Huang K. M. (2018). Honokiol Alleviates the Degeneration of Intervertebral Disc via Suppressing the Activation of TXNIP-NLRP3 Inflammasome Signal Pathway. Free Radic. Biol. Med. 120, 368–379. 10.1016/j.freeradbiomed.2018.04.008 Tian Y. Bao Z. Ji Y. Mei X. Yang H. (2020). Epigallocatechin-3-Gallate Protects H2O2-Induced Nucleus Pulposus Cell Apoptosis and Inflammation by Inhibiting cGAS/Sting/NLRP3 Activation. Drug Des. Devel Ther. 14, 2113–2122. 10.2147/dddt.s251623 Tian Z. Zhang X. Sun M. (2021). Phytochemicals Mediate Autophagy against Osteoarthritis by Maintaining Cartilage Homeostasis. Front. Pharmacol. 12, 795058. 10.3389/fphar.2021.795058 Turrens J. F. (2003). Mitochondrial Formation of Reactive Oxygen Species. J. Physiol. 552 (Pt 2), 335–344. 10.1113/jphysiol.2003.049478 Uddin S. J. Hasan M. F. Afroz M. Sarker D. K. Rouf R. Islam M. T. (2021). Curcumin and its Multi-Target Function against Pain and Inflammation: An Update of Pre-clinical Data. Curr. Drug Targets 22 (6), 656–671. 10.2174/1389450121666200925150022 Vistoli G. De Maddis D. Cipak A. Zarkovic N. Carini M. Aldini G. (2013). Advanced Glycoxidation and Lipoxidation End Products (AGEs and ALEs): an Overview of Their Mechanisms of Formation. Free Radic. Res. 47 (Suppl. 1), 3–27. 10.3109/10715762.2013.815348 Vo N. V. Hartman R. A. Patil P. R. Risbud M. V. Kletsas D. Iatridis J. C. (2016). Molecular Mechanisms of Biological Aging in Intervertebral Discs. J. Orthop. Res. 34 (8), 1289–1306. 10.1002/jor.23195 Vo N. V. Hartman R. A. Yurube T. Jacobs L. J. Sowa G. A. Kang J. D. (2013). Expression and Regulation of Metalloproteinases and Their Inhibitors in Intervertebral Disc Aging and Degeneration. Spine J. 13 (3), 331–341. 10.1016/j.spinee.2012.02.027 Wang D. He X. Wang D. Peng P. Xu X. Gao B. (2020a). Quercetin Suppresses Apoptosis and Attenuates Intervertebral Disc Degeneration via the SIRT1-Autophagy Pathway. Front. Cell Dev. Biol. 8, 613006. 10.3389/fcell.2020.613006 Wang H. Jiang Z. Pang Z. Zhou T. Gu Y. (2020b). Acacetin Alleviates Inflammation and Matrix Degradation in Nucleus Pulposus Cells and Ameliorates Intervertebral Disc Degeneration In Vivo . Drug Des. Devel Ther. 14, 4801–4813. 10.2147/dddt.s274812 Wang J. Huang C. Lin Z. Pan X. Chen J. Zheng G. (2018a). Polydatin Suppresses Nucleus Pulposus Cell Senescence, Promotes Matrix Homeostasis and Attenuates Intervertebral Disc Degeneration in Rats. J. Cell Mol. Med. 22 (11), 5720–5731. 10.1111/jcmm.13848 Wang J. Nisar M. Huang C. Pan X. Lin D. Zheng G. (2018b). Small Molecule Natural Compound Agonist of SIRT3 as a Therapeutic Target for the Treatment of Intervertebral Disc Degeneration. Exp. Mol. Med. 50 (11), 1–14. 10.1038/s12276-018-0173-3 Wang K. Hu S. Wang B. Wang J. Wang X. Xu C. (2019). Genistein Protects Intervertebral Discs from Degeneration via Nrf2-Mediated Antioxidant Defense System: An In Vitro and In Vivo Study. J. Cell Physiol. 234 (9), 16348–16356. 10.1002/jcp.28301 Wang M. Gao H. Li W. Wu B. (2020c). Icariin and its Metabolites Regulate Lipid Metabolism: From Effects to Molecular Mechanisms. Biomed. Pharmacother. 131, 110675. 10.1016/j.biopha.2020.110675 Wang M. Liang Y. Chen K. Wang M. Long X. Liu H. (2022). The Management of Diabetes Mellitus by Mangiferin: Advances and Prospects. Nanoscale 14 (6), 2119–2135. 10.1039/d1nr06690k Wang R. Liu J. Wang Z. Wu X. Guo H. Jiao X. (2021a). Mangiferin Exert Protective Effects on Joints of Adjuvant-Induced Arthritis Rats by Regulating the MAPKs/NF-Κb Pathway of Fibroblast-like Synoviocytes. Int. Immunopharmacol. 101, 108352. 10.1016/j.intimp.2021.108352 Wang S. Lin B. Liu W. Wei G. Li Z. Yu N. (2020d). Acacetin Induces Apoptosis in Human Osteosarcoma Cells by Modulation of ROS/JNK Activation. Drug Des. Devel Ther. 14, 5077–5085. 10.2147/dddt.s275148 Wang S. Z. Rui Y. F. Lu J. Wang C. (2014). Cell and Molecular Biology of Intervertebral Disc Degeneration: Current Understanding and Implications for Potential Therapeutic Strategies. Cell Prolif. 47 (5), 381–390. 10.1111/cpr.12121 Wang X. Cai H. Chen Z. Zhang Y. Wu M. Xu X. (2021b). Baicalein Alleviates Pyroptosis and Inflammation in Hyperlipidemic Pancreatitis by Inhibiting NLRP3/Caspase-1 Pathway through the miR-192-5p/TXNIP axis. Int. Immunopharmacol. 101 (Pt B), 108315. 10.1016/j.intimp.2021.108315 Wang Y. Che M. Xin J. Zheng Z. Li J. Zhang S. (2020e). The Role of IL-1β and TNF-α in Intervertebral Disc Degeneration. Biomed. Pharmacother. 131, 110660. 10.1016/j.biopha.2020.110660 Wu C. Chen R. L. Wang Y. Wu W. Y. Li G. (2022). Acacetin Alleviates Myocardial Ischaemia/reperfusion Injury by Inhibiting Oxidative Stress and Apoptosis via the Nrf-2/HO-1 Pathway. Pharm. Biol. 60 (1), 553–561. 10.1080/13880209.2022.2041675 Wu Y. Xu S. Tian X. Y. (2020). The Effect of Salvianolic Acid on Vascular Protection and Possible Mechanisms. Oxid. Med. Cell Longev. 2020, 5472096. 10.1155/2020/5472096 Wu Y. Cai C. Xiang Y. Zhao H. Lv L. Zeng C. (2021). Naringin Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension through Endothelial-To-Mesenchymal Transition Inhibition. Front. Pharmacol. 12, 696135. 10.3389/fphar.2021.696135 Wuertz K. Quero L. Sekiguchi M. Klawitter M. Nerlich A. Konno S. (2011). The Red Wine Polyphenol Resveratrol Shows Promising Potential for the Treatment of Nucleus Pulposus-Mediated Pain In Vitro and In Vivo . Spine (Phila Pa 1976) 36 (21), E1373–E1384. 10.1097/BRS.0b013e318221e655 Xiao Q. Zhu W. Feng W. Lee S. S. Leung A. W. Shen J. (2018). A Review of Resveratrol as a Potent Chemoprotective and Synergistic Agent in Cancer Chemotherapy. Front. Pharmacol. 9, 1534. 10.3389/fphar.2018.01534 Xiao Z. Liu W. Mu Y. P. Zhang H. Wang X. N. Zhao C. Q. (2020). Pharmacological Effects of Salvianolic Acid B against Oxidative Damage. Front. Pharmacol. 11, 572373. 10.3389/fphar.2020.572373 Xiong J. Li S. Wang W. Hong Y. Tang K. Luo Q. (2013). Screening and Identification of the Antibacterial Bioactive Compounds from Lonicera japonica Thunb. Leaves. Food Chem. 138 (1), 327–333. 10.1016/j.foodchem.2012.10.127 Yang B. Ma S. Zhang C. Sun J. Zhang D. Chang S. (2021). Higenamine Attenuates Neuropathic Pain by Inhibition of NOX2/ROS/TRP/P38 Mitogen-Activated Protein Kinase/NF-ĸb Signaling Pathway. Front. Pharmacol. 12, 716684. 10.3389/fphar.2021.716684 Yang L. Rong Z. Zeng M. Cao Y. Gong X. Lin L. (2015). Pyrroloquinoline Quinone Protects Nucleus Pulposus Cells from Hydrogen Peroxide-Induced Apoptosis by Inhibiting the Mitochondria-Mediated Pathway. Eur. Spine J. 24 (8), 1702–1710. 10.1007/s00586-014-3630-2 Yang L. Chen Y. Liu Y. Xing Y. Miao C. Zhao Y. (2020). The Role of Oxidative Stress and Natural Antioxidants in Ovarian Aging. Front. Pharmacol. 11, 617843. 10.3389/fphar.2020.617843 Yin M. Liu Y. Chen Y. (2021). Iron Metabolism: an Emerging Therapeutic Target Underlying the Anti-cancer Effect of Quercetin. Free Radic. Res. 55 (3), 296–303. 10.1080/10715762.2021.1898604 Yu H. Hou G. Cao J. Yin Y. Zhao Y. Cheng L. (2021). Mangiferin Alleviates Mitochondrial ROS in Nucleus Pulposus Cells and Protects against Intervertebral Disc Degeneration via Suppression of NF-Κb Signaling Pathway. Oxidative Med. Cell. Longev. 2021, 6632786. 10.1155/2021/6632786 Yun S. Lee Y.-J. Choi J. Kim N. D. Han D. C. Kwon B.-M. (2021). Acacetin Inhibits the Growth of STAT3-Activated DU145 Prostate Cancer Cells by Directly Binding to Signal Transducer and Activator of Transcription 3 (STAT3). Molecules 26 (20), 6204. 10.3390/molecules26206204 Zhang J. Fan F. Liu A. Zhang C. Li Q. Zhang C. (2022). Icariin: A Potential Molecule for Treatment of Knee Osteoarthritis. Front. Pharmacol. 13, 811808. 10.3389/fphar.2022.811808 Zhang Y. Yang B. Wang J. Cheng F. Shi K. Ying L. (2020). Cell Senescence: A Nonnegligible Cell State under Survival Stress in Pathology of Intervertebral Disc Degeneration. Oxid. Med. Cell Longev. 2020, 9503562. 10.1155/2020/9503562 Zhang Y. Zhang J. Wu C. Guo S. Su J. Zhao W. (2019). Higenamine Protects Neuronal Cells from Oxygen-Glucose Deprivation/reoxygenation-Induced Injury. J. Cell Biochem. 120 (3), 3757–3764. 10.1002/jcb.27656 Zhao H. Liu M. Liu H. Suo R. Lu C. (2020). Naringin Protects Endothelial Cells from Apoptosis and Inflammation by Regulating the Hippo-YAP Pathway. Biosci. Rep. 40 (3). 10.1042/bsr20193431 Zhao R. Liu X. Zhang L. Yang H. Zhang Q. (2019). Current Progress of Research on Neurodegenerative Diseases of Salvianolic Acid B. Oxidative Med. Cell. Longev. 2019–9. 10.1155/2019/3281260 Zheng X. X. Li Y. C. Yang K. L. He Z. X. Wang Z. L. Wang X. (2021). Icariin Reduces Glu-Induced Excitatory Neurotoxicity via Antioxidative and Antiapoptotic Pathways in SH-Sy5y Cells. Phytother. Res. 35 (6), 3377–3389. 10.1002/ptr.7057 Zheng Z. C. Zhu W. Lei L. Liu X. Q. Wu Y. G. (2020). Wogonin Ameliorates Renal Inflammation and Fibrosis by Inhibiting NF-Κb and TGF-β1/Smad3 Signaling Pathways in Diabetic Nephropathy. Drug Des. Devel Ther. 14, 4135–4148. 10.2147/dddt.s274256 Zhou R. Tardivel A. Thorens B. Choi I. Tschopp J. (2010). Thioredoxin-interacting Protein Links Oxidative Stress to Inflammasome Activation. Nat. Immunol. 11 (2), 136–140. 10.1038/ni.1831 Zhu H. Sun B. Shen Q. (2019). TNF-Α Induces Apoptosis of Human Nucleus Pulposus Cells via Activating the TRIM14/NF-Κb Signalling Pathway. Artif. Cells Nanomed Biotechnol. 47 (1), 3004–3012. 10.1080/21691401.2019.1643733 Zhu L. Yu C. Zhang X. Yu Z. Zhan F. Yu X. (2020). The Treatment of Intervertebral Disc Degeneration Using Traditional Chinese Medicine. J. Ethnopharmacol. 263, 113117. 10.1016/j.jep.2020.113117 Zhu Y. Wan N. Shan X. Deng G. Xu Q. Ye H. (2021). Celastrol Targets Adenylyl Cyclase-Associated Protein 1 to Reduce Macrophages-Mediated Inflammation and Ameliorates High Fat Diet-Induced Metabolic Syndrome in Mice. Acta Pharm. Sin. B 11 (5), 1200–1212. 10.1016/j.apsb.2020.12.008